Tag: review

Posts with tag: review

Latest Posts

Asian Markets Gain as Alibaba Leads Tech Rally; Yen Drops

Alibaba earnings boost Asian stocks, with Chinese tech shares leading gains; yen weakens past 150 per dollar; Alibaba's AI focus drives global fund inflows; BOJ rate hike speculation lifts USD/JPY; S&P 500 falls as Walmart results weigh; Treasury yields steady; oil set for weekly gain on supply uncertainty; gold holds near record amid safe-haven demand.

US Stocks Reel on Walmart Woes, Trump Tariffs

US stocks pulled back on Thursday as investors assessed Walmart's cautious outlook and the impact of President Trump's planned tariffs and policy shifts. The Dow Jones Industrial Average (^DJI) fell roughly 450 points, or around 1%. The S&P 500 (^GSPC) dropped 0.5%, pulling back after its second record close in a row on Wednesday, while the tech-heavy Nasdaq Composite (^IXIC) also lost about 0.5%.

Carvana Posts Q4 Beat, Shares Slip After Hours

Carvana reports Q4 revenue and profit beat, but shares dip after-hours; full-year sales hit record 416,000 units, adjusted EBITDA margin of 10.1%.

Amazon Web Services and Memorial Sloan Kettering Partner on Cancer Research

Amazon Web Services (AMZN) and Memorial Sloan Kettering (MSK) partner to advance cancer patient treatments and research through AI-powered data analysis.

Asian Central Banks Increasingly Use Derivatives to Protect Currencies

Central banks in Asia increasingly rely on derivatives to defend currencies against the strong dollar, sparking concerns about future issues.

Amazon Workers in North Carolina Vote Against Union

Amazon warehouse workers in North Carolina vote against unionization, marking a setback for labor organizers. Despite efforts by the union, about three-quarters of voters opposed the measure, continuing Amazon's successful resistance to organized labor at its facilities.

Telehealth stock Hims & Hers surges on weight-loss drug ad controversy and HHS nominee

Hims & Hers stock surges on telehealth weight-loss ad controversy; FDA removes Lilly's tirzepatide drugs from shortage list, but concerns remain about Novo's semaglutide supply.

Coinbase Shares Tumble Despite Solid Q4 Report, Mixed Guidance

Coinbase stock edged lower after reporting better-than-expected Q4 earnings, but analysts see upside ahead, citing a favorable regulatory outlook and ongoing crypto momentum.

Market Recon: Stocks Advance on Tariff Delay, Digesting Inflation Data

US stocks surged on Thursday after President Donald Trump announced plans to implement reciprocal tariffs while delaying their execution, as investors analyzed a report suggesting inflation is rising again. The Dow Jones Industrial Average (^DJI) gained over 0.7%, or 350 points, while the S&P 500 (^GSPC) rose over 1% to close at 6,115.06, just shy of its record 6,118.71. The tech-heavy Nasdaq Composite (^IXIC) jumped by more than 1.5% as Nvidia (NVDA) and Tesla (TSLA) rallied.

US companies recalibrate DEI policies in response to Trump's executive orders

Randstad CEO: Trump's DEI changes "bleaker than reality" as companies adjust